Skip to main content
    L

    LivaNova PLC (LIVN)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $92.44
    +1.12 (+1.23%)

    Market Cap: $5.03B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    LivaNova PLC (LIVN) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    LivaNova (LIVN) trades at 23.8x trailing earnings and 3.5x sales. Its P/E of 23.8x is above its 5-year median of 18.8x. Its forward P/E is 18.8x. The median P/E across 9 similar companies is 23.9x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 26.6% higher over the next year. Its free cash flow yield is 2.4%.

    MultipleValue
    P/E (trailing)23.8x
    Forward P/E18.8x
    Price to sales3.5x
    Price to book3.9x
    EV/EBITDA23.9x
    Price to FCF41.1x
    EV/FCF39.1x
    PEG0.9
    FCF yield2.4%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 10.2% above 21.6x, its P/S is 25.0% above 2.8x and its P/B is 62.5% above 2.4x.

    MultipleCurrent5-year median10-year median
    P/E23.8x18.8x21.6x
    P/S3.5x2.5x2.8x
    P/B3.9x2.5x2.4x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 13.7x in 2024 to 52.1x in 2020.

    Year endPriceP/EP/SP/B
    2025$61.5316.4x2.4x2.8x
    2024$46.3113.7x2.0x1.9x
    2023$51.7418.4x2.4x2.2x
    2022$55.5423.1x2.9x2.5x
    2021$87.4341.2x4.3x3.6x
    2020$66.2152.1x3.4x2.9x
    2019$75.4324.5x3.4x2.6x
    2018$91.4725.8x4.0x3.0x
    2017$79.9222.6x3.2x2.1x
    2016$44.9717.8x1.8x1.3x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About LIVN

    What is LIVN's forward P/E ratio?

    LivaNova has a forward P/E ratio of 18.8x.

    Is LIVN stock overvalued?

    GNG's valuation label for LIVN is Fairly valued. Its P/E of 23.8x compares with a median of 23.9x across 9 similar companies.

    What is LIVN's price to sales ratio?

    LivaNova has a price to sales ratio of 3.5x.

    What is LivaNova's average P/E ratio over 5 years?

    LivaNova's median P/E over the last 5 years is 18.8x, from 60 month-end values through Oct 2026.

    What is LIVN's PEG ratio?

    LivaNova has a PEG ratio of 0.9.